Seminars in Oncology
Volume 33, Issue 5 , Pages 607-613, October 2006

Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Current Status and Future Applications

  • Allan J. Pantuck

      Affiliations

    • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
    • Corresponding Author InformationAddress correspondence to Allan J. Pantuck, MD, Department of Urology, David Geffen School of Medicine at UCLA, 66-118 Center for Health Sciences, Box 951738, Los Angeles, CA 90095-1738.
    • ,
  • George Thomas

      Affiliations

    • Department of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center, Beckman Research Institute, and Comprehensive Cancer Center, Duarte, CA.
    • ,
  • Arie S. Belldegrun

      Affiliations

    • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
    • ,
  • Robert A. Figlin

      Affiliations

    • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
    • Department of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center, Beckman Research Institute, and Comprehensive Cancer Center, Duarte, CA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00268-5

doi:10.1053/j.seminoncol.2006.06.002

Seminars in Oncology
Volume 33, Issue 5 , Pages 607-613, October 2006

Article Tools

* Image Usage & Resolution